Artikel in Fachzeitschriften
Adler, G., Fröhlich, L., Gertz, HJ., Hampel, H., Haupt, M., Jendroska, K., Kurz, A., Mielke, R., Müller-Thomsen, T. & Zedlick, D. (1999). Diagnostik und Therapie der Demenz in der Primärversorgung. Zeitschrift für Allgemeinmedizin, 75, 1-6.
Anchisi, D., Borroni, B., Franceschi, M., Kerrouche, N., Kalbe, E., Beuthien-Beumann, B., Cappa, S., Lenz, O., Ludecke, S., Marcone, A., Mielke, R., Ortelli, P., Padovani, A., Pelati, O., Pupi, A., Scarpini, E., Weisenbach, S., Herholz, K., Salmon, E., Holthoff, V., Sorbi, S., Fazio, F. & Perani, D. (2005). Heterogenity of Brain Glucose Metabolism in Mild Cognitive Impairment and Clinical Progression to Alzheimer Disease. Archives of Neurology, 62(11), 1728-1733.
Bohmer, KA., Alavi, A., Clark, CM., Salmon, E., de Leon, MJ., Mielke, R., Cummings, J L., Kowell, AP., Gambhir, SS., Hoh, CK. & Phelps, ME. (2001). Positron emission tomography in evaluation of dementia - regional brain metabolism and long-term outcome. Journal of the American Medical Association (JAMA), 286, 2120-2127.
Gragnaniello, D., Kessler, J., Bley, M. & Mielke, R. (1998). Abzeichnen und freies Zeichnen bei Alzheimer-Patienten mit unterschiedlicher Demenzausprägung. Nervenarzt, 69, 991-998.
Haupt, WF., Dietz, E., Mielke, R. & Kessler, J. (1994). Visual evoked potentials in Alzheimer's disease: Investigations in a PET- defined collective. International Journal of Neuroscience, 79, 59-66.
Heiss, WD., Kessler, J., Mielke, R., Szelies, B. & Herholz, K. (1994). Long-term effects of Phosphatidylserine, Pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia, 5, 88-98.
Heiss, WD., Kessler, J., Slansky, I., Mielke, R., Szelies, B. & Herholz, K. (1993). Metabolic activation by a visual recognition task for assessment of therapeutic efficacy in Alzheimer's disease. Annals of Nuclear Medicine, 7, 124-125.
Heiss, WD., Kessler, J., Slansky, I., Mielke, R., Szelies, B. & Herholz, K. (1993). Activation PET as an instrument to determine therapeutic efficacy. Annals of the New York Academy of Science, 695, 327-331.
Herholz, K., Bauer, B., Wienhard, K., Kracht, L., Mielke, R., Lenz, O., Strotmann, T. & Heiss, WD. (2000). In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: Comparison with blood flow and glucose metabolism. Journal of Neural Transmission, 107, 1457-1468.
Herholz, K., Kessler, J., Slansky, I., Mielke, R. & Heiss, WD. (1993). A model for separation of regional from global metabolic activation during continuous visual recognition. Annals of Nuclear Medicine, 7, 112-113.
Herholz, K., Nordberg, A., Salmon, E., Perani, D., Kessler, J., Mielke, R., Halber, M., Jelic, V., Almkvist, O., Collette, F., Alberoni, M., Kennedy, A., Hasselbalch, S., Fazio, F. & Heiss, WD. (1999). Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia & Geriatric Cognitive Disorders, 10, 494-504.
Herholz, K., Salmon, E., Perani, D., Baron, JC., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., Kalbe, E., Zündorf, G., Delbuecke, X., Pelati, O., Anchisi, D., Fazio, F., Kerrouche, N., Beuthien-Baumann, B., Menzel, C., Schröder, J., Kato, T., Arahata, Y., Henze, M. & Heiss, WD. (2002). Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET. Neuroimage, 17, 302-316.
Herholz, K., Schopphoff, HH., Schmidt, M., Mielke, R., Eschner, W., Scheidhauer, C., Schicha, H., Heiss, WD. & Ebmeier K. (2002). Direct comparison of spatially normalized PET and SPECT scans in Alzheimer disease. Journal of Nuclear Medicine, 43, 21-26.
Hilker, R., Mielke, R., Berthold, F., Schröder, R. & Heiss, WD. (1998). Diagnostik und Therapie sezernierender Keimzelltumoren des Zentralnervensystems. Nervenarzt, 69, 519-524.
Hügel, A. & Mielke R. (1994). Cytogenetic investigations from lymphocyte cultures of patients with probable Alzheimer's disease. Dementia, 5, 310-313.
Ichimiya, A., Herholz, K., Mielke, R., Kessler, J., Slansky, I. & Heiss, WD. (1994). Difference of regional cerebral metabolic pattern between presenile and senile dementia of Alzheimer type: a factor analytic study. Journal of the Neurological Sciences, 123, 11-17.
Kerrouche, N., Herholz, K., Mielke, R., Holthoff, V. & Baron, J-C. (2006). FDG Pet in vascular dementia: differentiation from Alzheimer`s disease using voxel-based multivariate analysis. Journal of Cerebral Blood Flow & Metabolism, 1-9.
Kessler, J., Bley, M., Kerkfeld, C., Mielke, R. & Kalbe, E. (1998). Wortgenerieren bei Alzheimer-Patienten - Strategien und Strukturen. Zeitschrift für Neuropsychologie, 8, 43-60.
Kessler, J., Bley, M., Mielke, R. & Kalbe, E. (1997). Strategies and Structures in Verbal Fluency Tasks. Behavioural Neurology, 10, 133-135.
Kessler, J., Fast, C. & Mielke, R. (1995). Zur Problematik der prämorbiden Intelligenzdiagnostik mit dem MWT-B bei Patienten mit der Alzheimerschen Erkrankung. Nervenarzt, 66, 696-702.
Kessler, J., Ghaemi, M., Mielke, R., Herholz, K. & Heiss, WD. (1996). Visual versus auditory memory stimulation in patients with probable Alzheimer's disease. Annals of the New York Academy of Science, 777, 233-239.
Kessler, J., Mielke, R., Grond, M., Herholz, K. & Heiss, WD. (2000). Frontal lobe tasks do not reflect frontal lobe function in patients with probable Alzheimer's disease. International Journal of Neuroscience, 104, 1-15.
Klinger, T., Ibach, B., Schoenknecht, P., Kamleiter, M., Silver, G., Schroeder, J. & Mielke, R. (2005). Effect of donepezil in patients with Alzheimer`s disease previously untreated or treated with memantine or nootropic agents in Germany: an observational study. Current Medical Research and Opinions, 21(5), 723-732.
Kohler, J., Riepe, MW., Jendroska, K., Pilartz, H., Adler, G., Berger, FM., Calabrese, P., Frölich, L., Gertz, HJ., Hampel, H., Haupt, M., Mielke, R., Paulus, HJ. & Zedlick, D. (2002). Frühdiagnostik und Therapie der Alzheimer- Krankheit. Fortschritte der Medizin, Sonderdruck, 120, 135-141.
Kohler, J., Riepe, MW., Jendroska, K., Pilartz, H., Adler, G., Berger, FM., Calabrese, P., Frölich, L., Gertz, HJ., Hampel, H., Haupt, M., Mielke, R., Paulus, HP. & Zedlick, D. (2002). Sorgfältige Dokumentation schützt vor Regress. Fortschritte der Medizin, Sonderdruck, 144 (47), 53-54.
Lu, JH., Mielke, R., Emons, D. & Kowalewski, S. (1987). Konnataler Hydrozephalus bei angeborenen suprasellären Arachnoidalzysten. Ultraschall in Klinik und Praxis, 2, 172-174.
Lu, JH., Mielke, R., Emons, D. & Kowalewski, S. (1988). Neuroradiologische Diagnostik der Lissenzephalie-Syndrome Typ II. Ultraschall in Klinik und Praxis, 3, 29-34.
Lu, JH., Mielke, R., Emons, D. & Kowalewski, S. (1991). Ventrikulomegalie und Hydrozephalus bei Reifungsstörungen des Kortex. Ultraschall in Klinik und Praxis, 5, 262-269.
Lu, JH., Mielke, R., Le, TP., Emons, D. & Kowalewski, S. (1990). Schizenzephalie. Klinische Pädiatrie, 202, 106-108.
Maelicke, A., Mielke, R. & Schmitt, A. (2005). Dualer Wirkmechanismus von Galantamin zur Behandlung der Alzheimer Demenz. Psychoneuro, 31(5), 243-246.
Mielke, R. (1996). Neuroprotektive Therapie des Morbus Alzheimer. Deutsche Medizinische Wochenschrift, 48, 1515.
Mielke, R. & Fleck, S. (2006). Das neuropsychologische Gutachten in der Schadensbeurteilung bei Schädel-Hirn-Traumata. Forum Medizinische Begutachtung, 2, 16-18.
Mielke, R., Ghaemi, M., Kessler, J., Kittner, B., Szelies, B., Herholz, K. & Heiss, WD. (1998). Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer´s disease. Journal of the Neurological Sciences, 154, 76-82.
Mielke, R., Ghaemi, M., Kittner, B., Kessler, J., Szelies, B., Herholz, K. & Heiss, WD. (1996). Propentofylline improves regional cerebral glucose metabolism and neuropsychological performance in vascular dementia. Journal of the Neurological Sciences, 141, 59-64.
Mielke, R. & Heiss, WD. (1998). Positron-emission-tomography for diagnosis of Alzheimer´s disease and vascular dementia. Journal of Neural Transmission, 53, 237-250.
Mielke, R., Herholz, K., Fink, G., Kessler, J. & Heiss, WD. (1995). Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease. International Journal of Neuroscience, 82, 1-9.
Mielke, R., Herholz, K., Grond, M., Kessler, J. & Heiss, WD. (1992). Severity of vascular dementia is related to volume of metabolically impaired tissue. Archives of Neurology, 49, 909-913.
Mielke, R., Herholz, K., Grond, M., Kessler, J. & Heiss, WD. (1992). Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiology of Aging, 13, 93-98.
Mielke, R., Herholz, K., Fink, G., Ritter, D. & Heiss, WD. (1993). Positron emission tomography in myotonic dystrophy. Psychiatry Research - Neuroimaging, 50, 93-99.
Mielke, R., Herholz, K., Grond, M., Kessler, J. & Heiss, WD. (1994). Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia, 5, 36-41.
Mielke, R. & Kessler, J. (2007). From normal to pathological ageing – the spectrum of mild cognitive impairment and Alzheimer’s Disease. European Neurological Disease, 74-77.
Mielke, R., Kessler, J., Szelies, B., Herholz, K., Wienhard, K. & Heiss, WD. (1996). Vascular dementia: perfusional and metabolic disturbances and effects of therapy. Journal of Neural Transmission, 47, 183-191.
Mielke, R., Kessler, J., Szelies, B., Herholz, K., Wienhard, K. & Heiss, WD. (1998). Normal and pathological aging - findings of positron-emission-tomography. Journal of Neural Transmission, 105, 821-837.
Mielke, R., Lu, JH., Kochs, G. & Kowalewski, S. (1987). Klinische und ätiopathogenetische Aspekte des Lissenzephalie-Syndroms Typ II. Monatsschrift Kinderheilkunde, 135, 780-783.
Mielke, R., Lu, JH. & Kowalewski, S. (1986). Zerebro-oculo-muskuläres Syndrom. Helvetica Paediatrica Acta, 41, 369-376.
Mielke, R., Lu, JH. & Kowalewski, S. (1988). Lissencephaly. European Journal of Pediatrics, 147, 447-448.
Mielke, R., Lu, JH. & Kowalewski, S. (1991). Nosologie und Ultraschallbefunde der Porenzephalien. Ultraschall in der Medizin, 12, 206-210.
Mielke, R., Pietrzyk, U., Jacobs, A., Fink, G., Ichimiya, A., Kessler, J., Herholz, K. & Heiss, WD. (1994). HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. European Journal of Nuclear Medicine, 21, 1052-1060.
Mielke, R., Schmid, G. & Kowalewski, S. (1986). Neugeborenenkrämpfe - Eine Übersicht über Symptomatik, Ätiologie, Therapie und Prognose. Klinische Pädiatrie, 198, 449-456.
Mielke, R., Schopphoff, HH., Kugel, H., Pietrzyk, U., Heindel, W., Kessler, J. & Heiss, WD. (2001). Relation between 1H MR spectroscopic imaging and regional cerebral glucose metabolism in Alzheimer's disease. International Journal of Neuroscience, 107, 233-245.
Mielke, R., Schröder, R., Fink, G., Kessler, J., Herholz, K. & Heiss, WD. (1996). Regional cerebral glucose metabolism and postmortem pathology in Alzheimer´s disease. Acta Neuropathologica, 91, 174-179.
Mielke, R. & Szelies, B. (2003). Neuronal plasticity in poststroke aphasia: insights by quantitative electroencephalography. Expert Review of Neurotherapeutics, 3, 373-380.
Mielke, R., Weber-Luxenburger, G., Hilker, R., Kessler, J. & Heiss, WD. (1998). Early-onset-cerebellar-ataxia (EOCA) with retained reflexes: reduced cerebellar benzodiazepine receptor binding, progressive metabolic and cognitive impairment. Movement Disorders, 13, 739-745.
Mielke, R., Weber-Luxenburger, G., Kessler, J., Szelies, B. & Heiss, WD. (1997). Widespread functional deficits in perception related networks demonstrated by PET in a case with simple visual seizures. Epilepsia, 38, 370-373.
Mielke, R., Weber-Luxenburger, G., Kessler, J., Szelies, B., Markowitsch, HJ. & Heiss, WD. (1998). Temporomesial epileptogenic focus in benign epilepsy of childhood with occipital paroxysms (BEOP). Neurocase, 4, 167-171.
Mielke, R., Zerres, K., Uhlhaas, S., Kessler, J. & Heiss, WD. (1998). ApoE polymorphism influences the cerebral metabolic pattern in Alzheimer´s disease. Neuroscience letters, 254, 49-52.
Pietrzyk, U., Herholz, K., Fink, G., Jacobs, A., Mielke, R., Slansky, I., Würker, M. & Heiss, WD. (1994). An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. Journal of Nuclear Medicine, 35, 2011-2018.
Riepe, MW., Frölich, L., Gertz, HJ., Haupt, M., Kohler, J., Mielke, R., von der Damerau-Dambrowski, V. & Kurz, A. (2005). Evidenzbasierte medikamentöse Therapie der Alzheimer-Erkrankung. Deutsches Ärzteblatt, 102(51-52), 26.
Silverman, DHS., Small, GW., Chang, CY., Lu, CS., de Aburto, MAK., Chen, W., Czernin, J., Rapoport, SI., Pietrini, P., Alexander, GE., Schapiro, MB., Jagust, WJ., Hoffman, JM., Welsh-Bohmer, KA., Alavi, A., Clark, CM., Salmon, E., de Leon, MJ., Mielke, R., Cummings, JL., Kowell, AP., Gambhir, SS., Hoh, CK. & Phelps, ME. (2001). Positron emission tomography in evaluation of dementia - regional brain metabolism and long-term outcome. Journal of the American Medical Association (JAMA), 286, 2120-2127.
Silverman, DHS., Small, GW., Chang, CY., Lu, CS., de Aburto, MAK., Chen, W.,Czernin, J., Rapoport, SI., Pietrini, P., Alexander, GE., Schapiro, MB., Jagust, WJ., Hoffman, JM., Welsh- Szelies, B., Mielke, R., Kessler, J., Heiss, WD. (2001). Restitution of alpha-topography by piracetam in post-stroke aphasia. International Journal of Clinical Pharmacology & Therapeutics, 39, 152-157.
Slansky, I., Herholz, K., Pietrzyk, U., Kessler, J., Grond, M., Mielke, R. & Heiss, WD. (1995). Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism. Neuroradiology, 37, 270-277.
Szelies, B., Mielke, R., Grond, M. & Heiss, WD. (1995). P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism. Journal of the Neurological Sciences, 130, 77-81.
Szelies, B., Mielke, R., Herholz, K. & Heiss, WD. (1994). Quantitative topographical EEG compared to FDG-PET for classification of vascular and degenerative dementia. Electroencephalography and Clinical Neurophysiology, 91, 131-139.
Szelies, B., Mielke, R., Kessler, J. & Heiss, WD. (1999). Relation between rCMRGl and surface electroencephalographic activity in vascular dementia. Clinical Neurophysiology, 110, 615-620.
Szelies, B., Mielke, R., Kessler, J. & Heiss, WD. (2000). Die Bedeutung des quantitativen topographischen EEG für die Prognose der Aphasie nach Infarkt. Neurologie & Rehabilitation, 6, 295-299.
Szelies, B., Mielke, R., Kessler, J. & Heiss, WD. (2001). Restitution of alpha-topography by piracetam in post-stroke aphasia. International Journal of Clinical Pharmacology & Therapeutics, 39, 152-157.
Szelies, B., Mielke, R., Kessler, J. & Heiss, WD. (2002). Prognostic relevance of topographical EEG power in poststroke aphasia. Brain & Language, 82, 87-94.
Szelies, B., Mielke, R., Weber-Luxenburger, G., Kessler, J., Pietrzyk, U., Bauer, B. & Heiss, WD. (2000). Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry. European Journal of Neurology, 7, 393-400.
Szelies, B., Sobesky, J., Pawlik, G., Mielke, R., Bauer, B., Herholz, K. & Heiss, WD. (2002). Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by 11C-flumazenil PET. European Journal of Neurology, 9, 137-142.
Szelies, B., Weber-Luxenburger, G., Pawlik, G., Kessler, J., Holthoff, V., Mielke, R., Herholz, K., Bauer, B., Wienhard, K. & Heiss, WD. (1996). MRI guided Flumazenil and FDG-PET in temporal lobe epilepsy. Neuroimage, 3, 109-118.
Buchbeiträge
Kessler, J., Slansky, I., Grond, M., Herholz, K., Mielke, R. & Heiss, WD. (1996). Psychometrische Auffälligkeiten und zerebraler Glukosestoffwechsel bei der Demenz vom Alzheimer Typ. In Peters, UH., Schifferdecker, M. & Krahl, A. (Hrsg.), 150 Jahre Psychiatrie, Band 2 (S. 402-404). Köln: Martini Verlag.
Mielke, R. (1996). Neuropsychologische Grundlagen der normalen und gestörten Funktion des Gedächtnisses. In de Boor, W., Frisch, W. & Rode, I. (Hrsg.), Vergessen - Verdrängen - Verleugnen. Schriftenreihe des Instituts für Konfliktforschung, Heft 17 (S. 59-67).
Mielke, R. (1996). Die Bedeutung bildgebender Verfahren zur Diagnose hirnatrophischer Prozesse. In Huffmann, G. & Braune, HJ. (Hrsg.), Zerebrale und spinale Prozesse (S. 267-275). Einhorn-Presse Verlag.
Mielke, R. (1997). Positronen-Emissions-Tomographie in der Diagnose, Differentialdiagnose und im Verlauf degenerativer Hirnerkrankungen. In Huffmann, G., Braune, HJ., Fritz, C. & Rössy, W. (Hrsg.), Vegetativum - Schlaf - Schmerz (S. 531-538). Einhorn-Presse Verlag.
Mielke, R. (2000). Hirnchirurgie bei krankhafter Hypersexualität? In de Boor, W., Haffke, B. & Lange-Joest, C. (Hrsg.), Was tun mit Sexualstraftätern - Rationalität und Irrationalität der Reaktionen in Politik, Justiz und Gesellschaft, Heft 20.
Mielke, R., Grond, M., Herholz, K., Kessler, J. & Heiss, WD. (1996). Beitrag der Positronen-Emissions-Tomographie zur Diagnose und zum pathogenetischen Verständnis der Alzheimer Demenz. In Peters, UH., Schifferdecker, M. & Krahl, A. (Hrsg.), 150 Jahre Psychiatrie, Band 2 (S. 182-184). Köln: Martini Verlag.
Mielke, R. & Heiss, WD. (2000). Alzheimer´s disease and other degenerative dementias - need for an early diagnosis. In Maj, E. & Sartorius, N. (eds.), WPA (World Psychiatry Association) Series „Evidence and Practice in Psychiatry"; commentary on the chapter „Neuropsychological and instrumental diagnosis of Alzheimer´s disease and related dementia disorders" by O. Almkvist (S. 182-184).
Mielke, R. & Heiss, WD. (2002). Vaskuläre Demenzen. In Förstl, H. (ed.), Lehrbuch der Gerontopsychiatrie und Gerontologie (S. 346-359). Thieme Verlag.
Mielke, R., Jacobs, A., Kessler, J., Herholz, K. & Heiss, WD. (1996). Sensitivität und Spezifizität von PET und SPECT bei degenerativen Hirnerkrankungen. In Möller, HJ., Müller-Spahn, F. & Kurtz, G. (Hrsg.), Aktuelle Perspektiven der Biologischen Psychiatrie (S. 738-742). Wien: Springer Verlag.
Mielke, R. & Kessler, J. (1997). Alterskorrelierte und genetisch basierte Hirnerkrankungen. In Markowitsch, HJ. (Hrsg.), Klinische Neuropsychologie, Enzyklopädie der Psychologie, Themenbereich C: Theorie und Forschung, Serie I: Biologische Psychologie, Bd.2 (S. 897-967). Göttingen: Hogrefe Verlag für Psychologie.
Übersichtsartikel
Heiss, WD., Szelies, B., Kessler, J., Mielke, R. & Herholz, K. (1994). Dementia: New diagnostic approaches and clinical classification. Revista Brasilianica Neurologica, 30, 30-39.
Kohler, J., Riepe, MW., Jendroska, K., Pilartz, H., Adler, G., Berger, FM., Calabrese, P., Frolich, L., Gertz, HJ., Hampel, H., Haupt, M., Mielke, R., Paulus, HJ. & Zedlick, D. (2002). Early diagnosis and therapy of Alzheimer dementia. Careful documentation prevents degeneration. Fortschritte der Medizin, 144, 53-54.
Mielke, R. (1993). Ins Gehirn geschaut - Diagnostik, Therapie- und Verlaufskontrolle bei Demenz vom Alzheimer Typ. Schriften des Arbeitskreises für Gesundheit im Alter, 27-29.
Mielke, R. (1996). Neuroprotektive Therapie des Morbus Alzheimer. Deutsche Medizinische Wochenschrift, 48, 1515.
Mielke, R. (2002). Galantamin (Reminyl). Internistische Praxis, 42, 849-853.
Mielke, R. (2003). Galantamin (Reminyl). Arzneimittel-, Therapie-Kritik & Medizin und Umwelt, 34, 329-333.
Mielke, R. & Kessler, J. (1991). Diagnostik von Demenzen. TW Neurologie Psychiatrie, 5, 329-342.
Mielke, R. & Kessler, J. (1994). Hirnleistungsstörungen. Heilberufe, 46, 14-16.
Mielke, R. & Kessler, J. (1995). Diagnostik der Alzheimer-Demenz. Therapiewoche, 45, 1342-1346.
Mielke, R., Kessler, J., Herholz, K. & Heiss, WD. (1996). Positronen-Emissions-Tomographie in der Diagnose, Differentialdiagnose und im Verlauf der Alzheimer-Erkrankung. Neuropsychiatrie, 10, 75-78.
Mielke, R., Möller, HJ., Erkinjuntii, T., Rosenkranz, B., Rother, M. & Kittner, B. (1998). Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials. Alzheimer´s Disease and Associated Disorders, 12, 29-35.
Monographien
Baller, G. & Mielke, R. (2007). Mental Walking. Übungsprogramm für Aufmerksamkeit und Gedächtnis. Frankfurt am Main: Merz.
Kessler, J., Schaaf, A. & Mielke, R. (1993). Fragmentierter Bildertest - ein Wahrnehmungs- und Gedächtnistest. Göttingen, Bern, Toronto, Seattle: Hogrefe, Verlag für Psychologie.
Mielke, R., Hufnagel, JM. & Hacke, W. (1996). Von zerebralen Durchblutungsstörungen zur vaskulären Demenz. In Aktuelles Wissen. Hoechst.
Mielke, R. & Kessler, J. (1994). Alzheimersche Erkrankung und andere Demenzen. Göttingen, Bern, Toronto, Seattle: Hogrefe, Verlag für Psychologie.
Publizierte Vorträge und Abstracts
Brand, M., Kalbe, E., Kessler, J. & Mielke, R. (1999). Beeinträchtigungen des kognitiven Schätzens bei Patienten mit der Alzheimerschen Erkrankung. Aktuelle Neurologie, 26, 48-49.
Brand, M., Kessler, J., Kalbe, E., Mielke, R. & Behrendt, J. (2000). How long is a fly? A test for cognitive estimation in patients with probable Alzheimer´s disease. Neurobiology of Aging, 21, 233.
Dietz, E., Haupt, WF. & Mielke, R. (1993). VEP bei der Demenz vom Alzheimer-Typ. Zeitschrift für EEG-EMG, 24, 192.
Heiss, WD., Kessler, J., Slansky, I., Mielke, R., Szelies, B. & Herholz, K. (1993). Therapeutic efficacy in Alzheimer's dementia demonstrated by metabolic activation studies. Annals of Neurology, 34, 256-257.
Heiss, WD., Kessler, J., Slansky, I., Mielke, R., Szelies, B. & Herholz, K. (1993). Longterm metabolic changes in Alzheimer's disease under various therapeutic interventions. Journal of Cerebral Blood Flow and Metabolism, 13, 5.
Heiss, WD., Mielke, R., Kessler, J., Ghaemi, M., Szelies, B., Kittner, B., Herholz, K. & Pietrzyk, U. (1995). Longitudinal study of propentofyllin in vascular dementia. Journal of Cerebral Blood Flow and Metabolism, 15, 106.
Heiss, WD., Mielke, R., Kessler, J., Grond, M. & Herholz, K. (1992). Impairment of cognitive functions is related to extent of disturbance in multiinfarct and degenerative dementia. Journal of Nuclear Medicine, 33, 940.
Herholz, K., Heiss, WD., Mielke, R., Grond, M. & Kessler, J. (1990). PET in the differential diagnosis and the evaluation of treatment in dementias. Symposium on Neuro-Imaging, Antwerpen, Book of abstracts, 19.
Herholz, K., Nordberg, A., Salmon, E., Perani, D., Kessler, J., Mielke, R., Halber, M., Jelic, V., Almkvist, O., Colette, F., Alberoni, M., Kennedy, A., Hasselbalch, S., Fazio, F. & Heiss, WD. (1998). Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Annals of Neurology, 44, 496-497.
Herholz, K., Perani, D., Nordberg, A., Salmon, E., Kessler, J., Mielke, R., Halber, M., Jelic, V., Almkvist, O., Collette, F., Alberoni, M., Kennedy, A., Hasselbalch, S., Fazio, F. & Heiss, WD. (1999). Prediction of progression in Alzheimer's disease by positron emission tomography (PET). European Journal of Clinical Investigation 29, (Suppl. 1), 73.
Herholz, K., Schopphoff, HH., Schmidt, M., Scheidhauer, K., Mielke, R., Schicha, H. & Heiss, WD. (2001). Direct comparison of spatially normalized PET and SPECT scans in Alzheimer disease. Journal of Nuclear Medicine, 42, 14.
Herholz, K., Slansky, I., Pietrzyk, U., Kessler, J., Grond, M., Mielke, R. & Heiss, WD. (1993). Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism. Journal of Cerebral Blood Flow and Metabolism, 13, 237.
Herholz, K., Wienhard, K., Bauer, B., Kracht, L., Mielke, R., Kessler, J., Schuster, A., Strotmann, T. & Heiss, WD. (1999). Non-invasive imaging of reduced acetylcholine esterase activity in Alzheimer's disease with PET. European Journal of Neurology, 6 (Suppl. 3), 26.
Kalbe, E., Kessler, J., Brand, M., Mielke, R. & Heiss, WD. (2000). Acalculia in Alzheimer´s disease and other dementias - patterns of deterioration. Neurobiology of Aging, 21, 231.
Kessler, J., Ghaemi, M., Mielke, R. & Herholz, K. (1995). Auditory and visual memory tasks lead to cerebellar activation in patients with Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism, 15, 798.
Kessler, J., Herholz, K., Grond, M., Mielke, R. & Heiss, WD. (1991). Reduced metabolic reserve in Alzheimer's disease by cognitive stimulation and PET. Journal of Cerebral Blood Flow and Metabolism, 11(2), 15.
Kessler, J., Herholz, K., Slansky, I., Mielke, R., Grond, M. & Heiss, WD. (1993). Does impairment of frontal lobe task reflect frontal lobe degeneration in patients with probable Alzheimer's disease? Journal of Cerebral Blood Flow and Metabolism, 13, 236.
Kessler, J., Kalbe, E., Mielke, R. & Heiss, WD. (1996). Specific Errors in Numeral Transcoding in Patients with Alzheimer's Disease. Neurobiology of Aging, 17, 51.
Kugel, H., Naumann, B., Mielke, R. & Heindel, W. (1998). MRspektroskopische Bildgebung und neuropsychologische Tests bei Morbus Alzheimer: Korrelationen von Metabolitenintensitäten und Memo-1-Test. Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin, 168, 158.
Kugel, H., Naumann, B., Mielke, R. & Heindel, W. (1998). MRSI and neuropsychological tests in patients with Alzheimer´s disease: NAA/Cr in paravisual and temporoparietal cortex correlated with memo 1 test. In Proceedings of the international Society for magnetic resonance in medicine, 2, 726.
Lu, JH., Emons, D., Mielke, R. & Kowalewski, S. (1988). Sonographic features of cortical developmental disorders in newborns. Pediatric Radiology, 18, 257.
Lu, JH., Hanau, D., Mielke, R., Kowalewski, S., Hofmann, D., Knoepfle, G. & Foedisch, HJ. (1990). Sonographic estimation of cerebral cortex maturation - a comparative sonographic-pathoanatomic study. Early Human Development, 21, 135.
Lu, JH., Mielke, R., Emons, D. & Kowalewski, S. (1987). Sonographische Darstellung der normalen Sulci und Gyri Neugeborener - Vergleich mit der embryonalen Entwicklung. Monatsschrift Kinderheilkunde, 135, 604.
Lu, JH., Mielke, R., Emons, D. & Kowalewski, S. (1988). Fetal intracranial hemorrhage in the neonate. Pediatric Radiology, 18, 273.
Lu, JH., Mielke, R., Emons, D. & Kowalewski, S. (1989). Migrational disorders of neocortex presenting as connatel hydrocephalus in neonate: comparison of different diagnostic imaging (US, CT and MR). Pediatric Radiology, 19, 282.
Lu, JH., Mielke, R. & Kowalewski, S. (1986). Hydrozephalus und Ventrikulomegalie bei Reifungsstörungen des Gehirns im Neugeborenenalter. Ultraschall in Klinik und Praxis, 1, 34.
Lu, JH., Mielke, R. & Kowalewski, S. (1986). Differentialdiagnose des konnatalen Hydrozephalus bei Hirnmißbildungen. Monatsschrift Kinderheilkunde, 134, 641.
Mielke, R., Ghaemi, M., Kessler, J., Kittner, B., Herholz, K. & Heiss, WD. (1996). Activation PET demonstrates neurotrophic properties of propentofylline in Alzheimer´s disease. Annals of Neurology, 40, 501.
Mielke, R., Ghaemi, M., Kittner, B., Kessler, J., Herholz, K. & Heiss, WD. (1996). Propentofylline enhances brain activation during memory stimulation in Alzheimer´s disease - a PET study with 18-FDG. Neurobiology of Aging, 17, 153.
Mielke, R., Ghaemi, M., Löttgen, J., Kessler, J., Herholz, K. & Heiss, WD. (1996). Cerebral blood flow and metabolism are coupled in vascular dementia. Cerebrovascular Diseases, 6, 8.
Mielke, R., Grond, M., Halber, M., Kessler, J., Herholz, K. & Heiss, WD. (1992). Untersuchungen zur Pathogenese von vaskulären und primär-degenerativen Demenzen mittels Positronen-Emissions-Tomographie. Fortschritte der Neurologie und Psychiatrie, 60, 199.
Mielke, R. & Heiss, WD. (1992). Beitrag der Positronen-Emissions-Tomographie zum pathogenetischen Verständnis der Alzheimer Demenz. Fortschritte der Neurologie und Psychiatrie, 60, 129.
Mielke, R., Herholz, K., Grond, M., Kessler, J. & Heiss, WD. (1992). Extent of metabolic impairment correlates to severity of vascular dementia. Journal of Neurology, 239, 102.
Mielke, R., Herholz, K., Kessler, J., Fink, G. & Heiss, WD. (1993). FDG-PET and fragmented picture test demonstrate disturbed processing of visual information in dementia of Alzheimer type. Journal of Cerebral Blood Flow and Metabolism, 13, 238.
Mielke, R., Herholz, K., Kessler, J., Grond, M. & Heiss, WD. (1992). Regional cerebral glucose metabolism in vascular dementia. Journal of Stroke and Cerebrovascular Diseases, 2, 57.
Mielke, R., Herholz, K., Pietrzyk, U., Jacobs, A., Wienhard, K. & Heiss, WD. (1994). Metabolic correlates of impaired frontal HMPAO uptake - a PET-SPECT-study. European Journal of Nuclear Medicine, 21, 721.
Mielke, R., Jacobs, A., Kessler, J., Pietrzyk, U., Herholz, K. & Heiss, WD. (1995). Diagnostic accuracy of FDG PET and HMPAO SPECT for the differentiation between Alzheimer´s disease and vascular dementia depends on severity of disease. Journal of Neurology, 241, 35.
Mielke, R., Kessler, J., Fink, G., Herholz, K. & Heiss, WD. (1992). Processing of visual information in dementia of Alzheimer type - correlation between positron emission tomography and fragmented picture test. Journal of Neurology, 239, 17.
Mielke, R., Kessler, J., Herholz, K. & Heiss, WD. (1994). Vergleich von PET und SPECT bei Demenzen. Fortschritte der Neurologie und Psychiatrie, 62, 62-63.
Mielke, R., Kessler, J., Hilker, R., Weber-Luxenburger, G. & Heiss, WD. (1997). Metabolic and neuropsychological changes in early-onset-cerebellar-ataxia demonstrate cerebellar contribution to higher cortical functions. Experimental Brain Research, 117, 24-25.
Mielke, R., Kessler, J., Szelies, B. & Wullen, T. (1991). P300 and EEG frequency analysis in epileptic patients. Electroencephalography and Clinical Neurophysiology, 78, 49.
Mielke, R., Krull, F., Vartzopoulos, D. & Schmidt, R. (1988). Akute endokrinologische Störungen unter dem klinischen Bild neuropsychiatrischer Erkrankung. Intensivmedizin, 25, 364.
Mielke, R., Lu, JH., Emons, D. & Kowalewski, S. (1987). Sonographische Darstellung abnormer Gyrierung Neugeborener - Vergleich mit CT- und MR-Befunden. Monatsschrift Kinderheilkunde, 135, 604.
Mielke, R., Pietrzyk, U., Jacobs, A., Fink, G., Kessler, J., Herholz, K. & Heiss, WD. (1994). Diagnostic accuracy of HMPAO SPECT and FDG PET in primary degenerative and vascular dementia. Journal of Nuclear Medicine, 35, 119.
Mielke, R., Ritter, D., Fink, G., Herholz, K. & Heiss, WD. (1992). Myotonic dystrophy: further evidence of progeric features by positron emission tomography. Journal of Neurology, 239, 106.
Mielke, R., Schopphoff, HH., Pietrzyk, U., Kugel, H., Heindel, W. & Heiss, WD. (1998). Vergleich von 1H MR Spektroskopie und regionalem cerebralem Glukosestoffwechsel bei Patienten mit Alzheimer-Demenz. Aktuelle Neurologie, 25, 501.
Mielke, R., Schopphoff, HH., Pietrzyk, U., Kugel, H., Heindel, W. & Heiss, WD. (1999). Relation between quantitative H-1 MR spectroscopic imaging and cerebral glucose metabolism in Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism, 19 (Suppl. 1), 11.
Mielke, R., Schröder, R., Fink, GR., Herholz, K. & Kessler, J. (1995). Widespread impairment of regional cerebral glucose metabolism and distribution of neurofibrillary tangles suggest selective vulnerability in Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism, 15, 789.
Mielke, R., Strohmeier, M., Nekic, M., Bamborschke, S., Kessler, J. & Heiss, WD. (1999). Diagnostische Bedeutung von Tau im Liquor bei Alzheimer-Demenz, vaskulärer Demenz und verschiedenen dementiellen Erkrankungen. Aktuelle Neurologie, 26, 49.
Mielke, R., Strohmeier, M., Nekic, M., Bamborschke, S., Behrendt, J. & Heiss, WD. (2000). Improved diagnostic discrimination of patients with Alzheimer´s disease and vascular dementia using tau and ß-amyloid (1-42) levels in CSF. Neurobiology of Aging, 21, 227.
Mielke, R., Strohmeier, M., Nekic, M., Kessler, J. & Heiss, WD. (2003). Diagnostic significance of tau and beta-amyloid (1-42) CSF levels in vascular dementia. Journal of the Neurological Sciences, 313, 203-204.
Mielke, R., Szelies, B., Kessler, J., Rother, M. & Heiss, WD. (1996). Influence of Propentofylline on EEG-power in primary-degenerative and vascular demenita. Electroencephalography and Clinical Neurophysiology, 99, 322.
Mielke, R., Szelies, B., Kessler, J. & Wullen, T. (1990). P300 und EEG-Frequenzanalyse bei Epilepsiepatienten. Zeitschrift für EEG-EMG, 21, 194.
Mielke, R., Zerres, K., Uhlhaas, S., Kessler, J., Herholz, K. & Heiss, WD. (1997). ApoE polymorphism influences the cerebral metabolic pattern in Alzheimer´s disease. Journal of Cerebral Blood Flow and Metabolism, 17, 575.
Silverman, DHS., Small, GW., Kung de Aburto, MA., Hoffman, JM., Salmon, E., de Leon, MJ., Mielke, R., Jagust, WJ., Pietrini, P., Alexander, G., Furmuly, R., Czernin, J. & Phelps, ME. (2000). Diagnostic acuracy of FDG-PET in evaluation of dementia: international multi-center pooled brain scan and autopsy data. Journal of Nuclear Medicine, 41, 63.
Szelies, B., Mielke, R., Herholz, K., Grond, M., Scheller, G. & Heiss, WD. (1993). Relation between event-related potentials (P300), regional glucose metabolism (PET) and severity of Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism, 13, 235.
Szelies, B., Mielke, R., Herholz, K. & Heiss, WD. (1992). Quantitative EEG compared to FDG-PET for diagnostic assessment of vascular dementia. Journal of Stroke and Cerebrovascular Diseases, 2, 63.
Szelies, B., Mielke, R., Kessler, J. & Heiss, WD. (1996). Functional Disturbances in Vascular Dementia: EEG Power Mapping vs. PET of Glucose Metabolism. Cerebrovascular Diseases, 6, 13.
Szelies, B., Mielke, R., Kessler, J. & Heiss, WD. (1996). Quantitative topographical EEG compared to FDG PET in vascular dementia. Electroencephalography and Clinical Neurophysiology, 99, 393.
Szelies, B., Mielke, R., Kessler, J. & Heiss, WD. (1998). Die Bedeutung des quantitativen topographischen EEG für die Prognose der Aphasie nach ischämischem cerebralem Infarkt. Aktuelle Neurologie, 25, 124.
Szelies, B., Weber-Luxemburger, G., Pawlik, G., Pietrzyk, U., Kessler, J., Holthoff, V., Mielke, R., Herholz, K., Wagner, R. & Heiss, WD. (1995). Improved focus localization in temporal lobe epilepsy by MRI guided Flumazenil and FDG-PET. Journal of Cerebral Blood Flow and Metabolism, 15, 779.
Szelies, B., Weber-Luxenburger, G., Pietrzyk, U., Kessler, J., Holthoff, V., Mielke, R., Pawlik, G. & Heiss, WD. (1996). MRI-koregistrierte Flumazenil- und FDG-PET-Untersuchungen bei Temporallappen-Epilepsien. Epilepsie-Blätter, 9, 41.
Szelies, B., Weber-Luxenburger, G., Pietrzyk, U., Kessler, J., Holthoff, V., Mielke, R., Pawlik, G. & Heiss, WD. (1997). MRI Guided Flumazenil and FDG PET in Temporal Lobe Epilepsy. Epilepsia, 38, 378.
Szelies, B., Weber-Luxenburger, G., Pietrzyk, U., Kessler, J., Mielke, R., Holthoff, V., Bauer, B., Pawlik, G., Herholz, K. & Heiss, WD. (1996). Focus detection in temporal lobe epilepsy by MRI coregistered quantitative flumazenil and FDG PET. Neurology, 46, 123.
Szelies, B., Weber-Luxenburger, G., Pietrzyk, U., Mielke, R., Bauer, B. & Heiss, WD. (1997). Benzodiazepine receptor distribution and hippocampal volume in temporal lobe epilepsy. Annals of Neurology, 42, 406.
Szelies, B., Weber-Luxenburger, G., Pietrzyk, U., Mielke, R., Bauer, B. & Heiss, WD. (1997). Hippocampal volume and flumazenile binding in temporal lobe epilepsy. Journal of Cerebral Blood Flow and Metabolism, 17, 67.
Szelies, B., Weber-Luxenburger, G., Pietrzyk, U., Mielke, R., Bauer, B. & Heiss, WD. (1997). Volumetric versus functional analysis of hippocampus in temporal lobe epilepsy. Epilepsia, 38, 205.
Szelies, B., Weber-Luxenburger, G., Pietrzyk, U., Mielke, R., Bauer, B. & Heiss, WD. (1998). Hippokampusvolumetrie und quantitative Bestimmung der Benzodiazepin-Rezeptorendichte bei TLE. Epilepsie-Blätter, 11, 22.
Weber-Luxenburger, G., Szelies, B., Pietrzyk, U., Mielke, R., Bauer, B. & Heiss, WD. (1997). Hippokampusvolumen und Flumazenilbindungskapazität bei Temporallappen-Epilepsien. Epilepsie-Blätter, 10, 3.